Skip to content

New Feature Updates

New Feature Updates

It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users.  Those are the customizable consent and confirmation page features that can be enabled. Read below to see how you can use these features to make sure all patients are ready to go prior to your appointments and key information is reinforced, reducing time costly omissions.

Customize Your Consents

If you wish to create your own consents and make them part of your intake forms, we now have an easier process to do so. 

When logged in, hover over your settings and select the ‘Patient Portal’ setting.

Once there, turn the ‘Custom Consent’ to ‘Yes’ and a label and text box will appear.  Here you can enter the text that you require patients to sign. 

If you have more than one consent that you require, select the + button to the right of the text box to generate a new label and box.  When you are done, hit the ‘Update’ button.  The consent(s) will now be live on your intake forms and will be time-stamped, signed, and stored with the medical record.

Customize Your Intake Confirmation Page

If you want to remind patients of what to bring to an appointment, direct them to state registries, or simply just list your location again, we now have an easy way to do so with our ‘Directory Profile’ setting.

Once logged in, hover over Settings and select ‘Directory Profile’. 

Scroll down to the text box labeled ‘Thank You Page Text’ and type or paste your customized message.  The box accepts html so you can customize its content and appearance even more. Once you are done, select ‘Update’ and your new ‘Confirmation/Thank You’ page will be displayed after a patient completes the intake form.

Stories you may be interested in

States with medical marijuana laws saw 20 percent drop in some opioid prescriptions

States with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to states without medical marijuana programs, according to a first-of-its-kind study out of Columbia University’s Irving Medical Center. Authors said the findings underscore the importance of providing patients with pain management alternatives, such as cannabis, in efforts to reduce…
Read More

Doctors and patients are flying blind as medical marijuana use rises, research lags

Marijuana’s role in the health care universe has grown exponentially over the past few years. Currently, 33 U.S. states have legalized the use of medical marijuana, and more and more states are considering making it legal for recreational purposes as well. As cannabis becomes more accessible, many people are turning to tetrahydrocannabinol (THC) and cannabidiol (CBD) products to…
Read More

Norfolk research company plans clinical trials using medical marijuana

Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More

Arfinn Med March Updates

We are very happy to announce the release of several new functions within the Arfinn Med Platform.  Those include: * Text message updates from patients regarding their treatments * Templating for exam notes  * Updated analytics and dosing reports * Google calendar and Calendly integrations to schedule appointments. Please view the video below for more…
Read More

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders

Report of the Guideline Development Subcommittee of the American Academy of Neurology:   We performed a systematic review of medical marijuana (1948–November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders. We graded the studies according to the American Academy of Neurology classification scheme for therapeutic articles. Read the full…
Read More

Leave a Comment

You must be logged in to post a comment.